HeartBeam appoints Timothy Cruickshank as CFO; base salary $385K plus equity

HeartBeam, Inc.

Timothy Cruickshank appointed CFO effective September 9, 2024.
Annual base salary of $385,000; eligible for 45% incentive bonus and 400,000-share option grant.
Cruickshank was CFO of ImpediMed from Oct 2019 to Mar 2024 with 15+ years medtech experience.
Succeeds Richard Brounstein, who retired in February and remained in advisory capacity.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Timothy Cruickshank

Chief Financial Officer

BEAT · HeartBeam, Inc.

Effective: 2024-09-09
Filed: September 10, 2024, 7:59 PM ET

On August 22, 2024, the Board of Directors (the “ Board ”) of HeartBeam, Inc. (the “ Company ”) appointed Timothy Cruickshank as Chief Financial Officer of the Company (the “ Appointment ”) effective as of September 9, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Timothy Cruickshank was appointed as Chief Financial Officer at HeartBeam, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On August 22, 2024, the Board of Directors (the “ Board ”) of HeartBeam, Inc. (the “ Company ”) appointed Timothy Cruickshank as Chief Financial Officer of the Company (the “ Appointment ”) effective as of September 9, 2024.

View on SEC.gov

HeartBeam, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-039968

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.